HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Examples include dulaglutide ... [5] Dulaglutide: A type of glucagon-like peptide-1 (GLP-1) receptor agonist approved by the ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Researchers are weighing the effects of popular weight-loss medications like Ozempic on muscle mass. New work is "calling ...